| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/15/1998 | EP0835266A1 Modified/chimeric superantigens and their use |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835260A1 Novel antiproliferative protein from bacillus thuringiensis var. thuringiensis |
| 04/15/1998 | EP0835258A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 04/15/1998 | EP0835257A1 Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835134A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835124A1 Serum preparations for inhibiting retroviruses and tumor growth |
| 04/15/1998 | EP0835111A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 04/15/1998 | EP0835108A1 Use of lamellarin-class alkaloids in methods of treatment |
| 04/15/1998 | EP0699204B1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 04/15/1998 | EP0678025B1 Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
| 04/15/1998 | EP0667771B1 Antitumour compositions containing taxane derivatives |
| 04/15/1998 | CN1179158A 4 -amino -3 -acylnaphthyridine derivatives |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/14/1998 | US5739359 Deacetylation; cyclizing to acetonide derivative; esterification; deprotecting |
| 04/14/1998 | US5739350 CC-1065 analogs |
| 04/14/1998 | US5739340 Indolizine derivatives with pharmaceutical activity |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739313 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 04/14/1998 | US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739167 Desferrioxamine-B salts and their use as orally effective iron chelators |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739130 Treating systemic lupus erythematosis, melanoma |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739116 Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 04/14/1998 | US5739115 Sulfated maltooligosaccharides with heparin-like properties |
| 04/14/1998 | US5739013 Enzymatic synthesis of 2',5'-oligoadenylate-2',3'-cyclophosphates and treatment of papillomaviruses |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |
| 04/14/1998 | US5739008 DNA encoding a protein comprising calmodulin-and actin-binding human caldesmon peptide fragment |
| 04/14/1998 | US5738867 Antigen encapsulated or conjugated to liposome carrier; antitumor agents |
| 04/14/1998 | US5738844 Polypeptides |
| 04/10/1998 | CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/10/1998 | CA2217373A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
| 04/10/1998 | CA2217235A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
| 04/10/1998 | CA2217135A1 Benzo-b-thiophene compounds, intermediates, formulations, and methods |
| 04/09/1998 | WO1998014598A1 INTERLEUKIN-1β CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014593A2 Human telomerase catalytic subunit |
| 04/09/1998 | WO1998014592A2 Telomerase reverse transcriptase |
| 04/09/1998 | WO1998014577A3 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014577A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014576A2 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | WO1998014566A1 Method for obtaining microorganisms capable of producing antitumor molecules |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014468A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | WO1998014459A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 04/09/1998 | WO1998014450A1 Pyrimidine derivatives and processes for the preparation thereof |
| 04/09/1998 | WO1998014446A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014445A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998014205A1 Cancer therapy using an oncogene product and a foreign mhc molecule |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | WO1998014190A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | WO1998014172A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 04/09/1998 | WO1998001156A3 Method for producing chlorins and bacteriochlorins containing polyether |
| 04/09/1998 | WO1997048804A3 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 04/09/1998 | WO1997045746A3 Prion protein binding proteins and uses thereof |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2268114A1 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267493A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267412A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267328A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2265558A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2237940A1 Method for obtaining microorganisms capable of producing antitumor molecules |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834556A1 Methods for culturing cells |
| 04/08/1998 | EP0834517A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 04/08/1998 | EP0834311A1 Method for inhibiting the growth of mammalian cells |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
| 04/08/1998 | EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 04/08/1998 | EP0833892A1 Human hepatoma-derived growth factor-2 |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833660A1 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 04/08/1998 | EP0833647A1 Method for treating tumors with a toxin |
| 04/08/1998 | EP0833641A1 Treatment and prevention of prostatic disease |
| 04/08/1998 | EP0833636A1 Method for inhibiting neoplastic disease in mammals |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |